UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
____________________
FORM 11-K
FOR ANNUAL REPORTS OF EMPLOYEE STOCK
PURCHASE, SAVINGS AND SIMILAR PLANS
PURSUANT TO SECTION 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
(Mark One):
☑ ANNUAL REPORT PURSUANT TO SECTION 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the fiscal year ended December 31, 2017
OR
☐ TRANSITION REPORT PURSUANT TO SECTION 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from ___________________ to ____________________
Commission file number 1-07151
A. Full title of the plan and the address of the plan, if different from that of the issuer named below:
The Clorox Company 401(k) Plan
(formerly The Clorox Company Employee Retirement Investment Plan)
B. Name of issuer of the securities held pursuant to the plan and the address of its principal executive office:
The Clorox Company
1221 Broadway
Oakland, CA 94612-1888
The Clorox Company 401(k) Plan
Financial Statements and Supplemental Information
As of December 31, 2017 and 2016
and for the Plan year ended December 31, 2017
Contents
| Report of Independent Registered Public Accounting Firm |
1 |
| Audited Financial Statements |
|
| Statements of Net Assets Available for Benefits | 3 |
| Statement of Changes in Net Assets Available for Benefits | 4 |
| Notes to Financial Statements |
5 |
| Supplemental Information |
|
| Schedule H, Line 4a – Schedule of Delinquent Participant Contributions | 15 |
| Schedule H, Line 4i – Schedule of Assets (Held at End of Year) |
16 |
| Exhibit 23.1 – Consent of Independent Registered Public Accounting Firm | 19 |
2
Report of Independent Registered Public Accounting Firm
To the Plan Administrator and Participants of
The Clorox Company 401(k) Plan
Opinion on the Financial Statements
We have audited the accompanying statements of net assets available for benefits of The Clorox Company 401(k) Plan (the “Plan”) as of December 31, 2017 and 2016, the related statement of changes in net assets available for benefits for the year ended December 31, 2017, and the related notes (collectively referred to as the “financial statements”). In our opinion, the financial statements present fairly, in all material respects, the net assets available for benefits of the Plan as of December 31, 2017 and 2016, and the changes in net assets available for benefits for the year ended December 31, 2017, in conformity with accounting principles generally accepted in the United States of America.
Basis for Opinion
These financial statements are the responsibility of the Plan’s management. Our responsibility is to express an opinion on the Plan’s financial statements based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (“PCAOB”) and are required to be independent with respect to the Plan in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.
We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. The Plan is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. As part of our audits we are required to obtain an understanding of internal control over financial reporting but not for the purpose of expressing an opinion on the effectiveness of the Plan’s internal control over financial reporting. Accordingly, we express no such opinion.
Our audits included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures to respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audits provide a reasonable basis for our opinion.
1
Opinion on the Supplemental Information
The supplemental information included in Schedule H line 4(a) – Schedule of Delinquent Participant Contributions and Schedule H, line 4(i) – Schedule of Assets (Held at End of Year) as of and for the year ended December 31, 2017 have been subjected to audit procedures performed in conjunction with the audit of the Plan’s financial statements. The supplemental information is the responsibility of the Plan's management. Our audit procedures included determining whether the supplemental information reconciles to the financial statements or the underlying accounting and other records, as applicable, and performing procedures to test the completeness and accuracy of the information presented in the supplemental information. In forming our opinion on the supplemental information in the accompanying schedules, we evaluated whether the supplemental information, including its form and content, is presented in conformity with DOL’s Rules and Regulations for Reporting and Disclosure under ERISA. In our opinion, the supplemental information in the accompanying schedules is fairly stated, in all material respects, in relation to the financial statements as a whole.
/s/ Moss Adams LLP
San Francisco, California
June 28, 2018
We have served as the Plan’s auditor since 2013.
2
The Clorox Company 401(k) Plan
Statements of Net Assets Available for Benefits
| December 31, | ||||||
| 2017 | 2016 | |||||
| Assets | ||||||
| Investments, at fair value | $ | 1,571,680,628 | $ | 1,311,717,909 | ||
| Receivables: | ||||||
| Notes receivable from participants | 19,275,955 | 21,690,549 | ||||
| Employer's contributions | 27,892,193 | 27,890,028 | ||||
| Total receivables | 47,168,148 | 49,580,577 | ||||
| Net assets available for benefits | $ | 1,618,848,776 | $ | 1,361,298,486 | ||
See accompanying notes to the financial statements.
3
The Clorox Company 401(k) Plan
Statement of Changes in Net Assets Available for Benefits
For the Plan Year Ended December 31, 2017
| Additions to (deductions from) net assets attributable to: | ||||
| Investment and other income: | ||||
| Interest income and dividends | $ | 19,033,412 | ||
| Net appreciation in fair value of investments | 235,428,398 | |||
| Total investment and other income | 254,461,810 | |||
| Contributions: | ||||
| Employer | 43,889,315 | |||
| Participants | 49,012,275 | |||
| Rollovers | 4,907,630 | |||
| Total contributions | 97,809,220 | |||
| Benefits paid to participants | (94,085,673 | ) | ||
| Administrative expenses | (635,067 | ) | ||
| Net increase | 257,550,290 | |||
| Net assets available for benefits: | ||||
| Beginning of year | 1,361,298,486 | |||
| End of year | $ | 1,618,848,776 | ||
See accompanying notes to the financial statements.
4
The Clorox Company 401(k) Plan
Notes to Financial Statements (continued)
1. Description of the Plan
The following description of The Clorox Company 401(k) Plan (the “Plan”) provides only general information. Participants should refer to the Plan document for a more complete description of the Plan’s provisions.
General
The Plan is a defined contribution plan covering substantially all employees of The Clorox Company and its affiliated companies that have adopted the Plan (“Participating Company”) (collectively referred to as “Company”). The following employees are not covered by the Plan: (i) leased employees (contractors), (ii) nonresident aliens with no United States of America source of income, (iii) employees covered by a collective bargaining agreement, unless such coverage is specified in the written agreement, (iv) employees sent to a Participating Company by an international subsidiary to participate in a training or development program sponsored by the Participating Company, and (v) employees who are residents of Puerto Rico or who perform services for a Participating Company primarily in Puerto Rico and are participants of The Clorox Company Employee Retirement Investment Plan for Puerto Rico. Participants are eligible to participate on the first day of employment with the Company. The Plan is subject to the provisions of the Employee Retirement Income Security Act of 1974, as amended (“ERISA”).
The Company maintains a non-leveraged employee stock ownership plan (the “ESOP”) within the meaning of Section 4975(e)(7) of the Internal Revenue Code of 1986, as amended (the “Code”). The ESOP is maintained as part of the Plan and is designed to invest in the Company’s common stock. If elected, participants can receive dividends paid directly to them in cash. No participant shall be permitted to direct more than 5% of the contributions to be made to the Plan on his or her behalf in the ESOP fund; and no participant shall be permitted to effect a transfer or exchange from another investment fund into the ESOP fund if the portion of the participant’s account invested in the ESOP fund would exceed 5% of his or her account balance immediately after such transfer or exchange. From January 1, 2007 up to December 31, 2012, the limit was 10%. Prior to January 1, 2007, there was no account limit implemented; as such there are certain participants whose investment in the ESOP fund exceeds 5% of their total account balance.
The Employee Benefits Committee (the “Committee”) administers the Plan. Mercer Trust Company (“Mercer”) was the trustee, custodian and recordkeeper of the Plan through December 31, 2016. Effective January 1, 2017, The Vanguard Fiduciary Trust Company and Vanguard Group, Inc. (“Vanguard”) became the trustee and recordkeeper, respectively.
5
The Clorox Company 401(k) Plan
Notes to Financial Statements (continued)
1. Description of the Plan (continued)
Contributions
Salary Deferral Contributions
The Plan allows for automatic enrollment for newly eligible participants who do not make a salary deferral contribution election, or fail to elect to decline a deferral contribution. The Plan also implements an automatic annual contribution rate increase until a set contribution rate is reached unless another annual percentage is elected or the automatic election is declined by the eligible participant.
| Automatic enrollment rate | 6% |
| Contribution rate below which will trigger annual increase | 20% |
| Annual increase in contribution rate if triggered | 2% |
Participants may contribute from 1% to 50% of their covered compensation, on a pre-tax and after-tax basis, as defined in the Plan. Participants also have the option to contribute on a Roth basis. The combined pre-tax, after-tax and Roth contributions cannot exceed the 50% limit. Generally, covered compensation consists of regular pay plus most bonuses, overtime and vacation pay. It does not include, for example, short or long term disability pay, relocation, severance, deferred compensation, stock compensation, or Worker’s Compensation pay. Participant contributions are subject to limits specified under the Code.
Matching Contributions
Employees not covered by a collective bargaining agreement, are eligible to receive a matching contribution of 100% of salary deferral contributions, including pre-tax, after-tax and Roth contributions, up to a maximum of 4% of covered compensation.
Certain participants covered by a collective bargaining agreement are eligible to receive a Company match of 100% of salary deferral contributions, including pre-tax, after-tax and Roth contributions up to a maximum amount of $1,200 for those whose last date of hire was prior to January 1, 2005 and up to 3% of eligible compensation for those whose last date of hire is on or after January 1, 2005.
Participants are eligible for the Company matching contribution after completing one year of service. Matching contributions are funded each pay period.
6
The Clorox Company 401(k) Plan
Notes to Financial Statements (continued)
1. Description of the Plan (continued)
Non-elective Employer Contributions
Participants are also eligible for a non-elective employer contribution. To receive a non-elective employer contribution for a particular Plan year, a participant must have completed at least one year of service prior to December 31 of the Plan year. A participant must also have been an eligible employee sometime during the Plan year and have been employed with the Company on December 31 of the Plan year or have separated from service during the Plan year due to death or certified disability, attainment of age 60 or attainment of age 55 and 10 years of service.
The non-elective employer contribution is equal to 6% of covered compensation or 2.5% of covered compensation for eligible Kingsford Participants during the Plan year. The non-elective employer contributions are funded during the quarter subsequent to the Plan year end. See “Vesting” section for more information.
Rollover Contributions
Participants may also rollover amounts representing distributions from other qualified defined benefit or defined contribution plans. Subject to Committee discretion, participants may also rollover outstanding loans under a plan sponsored by an entity that was acquired by or merged with the Company.
Investment Options
Participants direct the investment of their contributions and the Company contributions into the various investment options offered by the Plan. The Plan offers investments in mutual funds, common collective trust funds, and the Company’s common stock. Participants are also allowed to direct their contributions to TD Ameritrade, a self-directed brokerage account which permits investments in additional mutual funds, common stocks, and other investment products. Effective January 1, 2017 with the transition to Vanguard, the self-directed brokerage account transferred from TD Ameritrade to Vanguard.
7
The Clorox Company 401(k) Plan
Notes to Financial Statements (continued)
1. Description of the Plan (continued)
Participant Accounts and Forfeitures
Each participant’s account is credited with the participant’s contribution and allocations of: (a) Company contributions and (b) Plan earnings. Allocations are based on participants’ eligible compensation for the employer match and non-elective employer contribution and investment balances for investment earnings. At the discretion of the Committee, forfeited balances of terminated participants’ nonvested accounts may be used to pay the Plan’s expenses, to reduce the Company’s contributions to the Plan, or to restore accounts of previously terminated participants who subsequently resumed employment with the Company. The amounts of unallocated forfeitures related to nonvested accounts at December 31, 2017 and 2016 are $1,067,000 and $948,600, respectively. Subsequent to year end, the Company used $1,023,000 and $1,053,191 of forfeitures to reduce the non-elective employer contribution for the Plan year ended December 31, 2017 and 2016, respectively.
Vesting
Participants are always fully vested in their individual contributions, Company matching contributions, and actual earnings thereon.
The non-elective employer contribution, will vest in varying rates over a period of 5 years as follows:
| Years of Service | Vesting Percentage | |||
| 1 | 0 | % | ||
| 2 | 20 | % | ||
| 3 | 40 | % | ||
| 4 | 70 | % | ||
| 5 | 100 | % | ||
Participants become immediately vested in the non-elective employer contributions upon reaching age 60 while employed by the Company, at death, or upon permanent disability.
Notes Receivable from Participants
Participants may borrow a minimum of $1,000 from their fund accounts up to a maximum equal to the lesser of $50,000 or 50% of their vested account balance. Loan terms range from one to 5 years, or up to 15 years if loan proceeds are used for the purchase of a primary residence. The loans are secured by the balance in the participant’s account and bear interest at a fixed rate (prime plus 1%) determined at the time of the loan. Principal and accrued interest are repaid ratably through payroll deductions or directly to the custodian by the participant.
8
The Clorox Company 401(k) Plan
Notes to Financial Statements (continued)
1. Description of the Plan (continued)
Payment of Benefits
The Plan allows for lump-sum and partial distributions of the vested value of a participant’s account at death, upon permanent disability, or upon termination of employment. Hardship and other in-service withdrawals are permitted if certain criteria are met.
Administrative Expenses
The Company pays substantially all administrative expenses except for certain investment fees and loan fees, which are deducted from the affected participant’s account. Quarterly recordkeeping fees are also deducted from participants’ accounts.
Plan Termination
Although it has not expressed any intent to do so, the Company has the right under the Plan to discontinue its contributions at any time and to terminate the Plan subject to the provisions of ERISA. In the event of the Plan’s termination, participants will become 100% vested in their accounts.
2. Summary of Accounting Policies
Basis of Accounting
The accompanying financial statements are prepared in accordance with generally accepted accounting principles in the United States of America (“U.S. GAAP”).
Investment Valuation and Income Recognition
The Plan’s investments are stated at fair value. Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. See Note 3 for further discussion of fair value measurements.
Purchases and sales of securities are recognized on a trade-date basis. Interest income is recorded on the accrual basis. Dividends are recorded on the ex-dividend date.
Notes Receivable from Participants
Notes receivable from participants are measured at their unpaid principal balance plus any accrued but unpaid interest. Delinquent participant loans are reclassified as distributions based upon the terms of the Plan Document.
9
The Clorox Company 401(k) Plan
Notes to Financial Statements (continued)
2. Summary of Accounting Policies (continued)
Risk and Uncertainties
The Plan provides for various participant directed investment options in mutual funds, common stocks, common collective trust funds, and a self-directed brokerage account. Investment securities, in general, are exposed to various risks, such as interest rate, credit, and overall market volatility risk. Due to the level of risk associated with certain investment securities, it is reasonably possible that changes in the values of investment securities will occur in the near term and that such changes could materially affect the amounts reported in the statements of net assets available for benefits, the statement of changes in net assets available for benefits, and participant account balances.
Payment of Benefits
Benefits paid to participants are recognized upon payment.
Use of Estimates
The preparation of financial statements in conformity with U.S. GAAP requires the Plan’s management to make estimates that affect the amounts reported in the financial statements and accompanying footnotes. Actual results could differ from those estimates.
3. Fair Value Measurements
Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date (i.e., an exit price). Fair value is determined based on a hierarchy that prioritizes the inputs to valuation techniques used to measure fair value. An asset’s or liability’s classification is based on the lowest level of input that is significant to the fair value measurement. Assets and liabilities carried at fair value are classified and disclosed in one of the following categories:
| Level 1 – | Quoted market prices in active markets for identical assets or liabilities. | |
| Level 2 – | Observable market-based inputs or unobservable inputs that are corroborated by market data. | |
| Level 3 – | Unobservable inputs reflecting management’s own assumptions. |
10
The Clorox Company 401(k) Plan
Notes to Financial Statements (continued)
3. Fair Value Measurements (continued)
The following is a description of the valuation methodologies used for assets and liabilities measured at fair value:
Mutual funds: Valued at quoted market prices of shares held by the Plan at year-end.
Company’s common stock (and other common stocks as part of self-directed brokerage account): Valued at the last reported quoted market sales price at year-end.
Interest bearing accounts (part of self-directed brokerage account): Valued at cost plus accrued interest, which approximates fair value, at year-end.
Common collective trust funds: Valued using the market approach at a net asset value per share (“NAV” as a practical expedient) determined by the portfolio’s sponsor based on the fair value of underlying investments held by the fund on the last business day of the Plan year. These are not classified in the fair value hierarchy table. The fair values are included in the table to allow reconciliation of the fair value hierarchy to the fair value of investments per the statement of net assets available for benefits.
The methods described above may produce a fair value calculation that may not be indicative of net realizable value or reflective of future fair values. Furthermore, while the Plan believes its valuation methods are appropriate and consistent with other market participants, the use of different methodologies or assumptions to determine the fair value of certain financial instruments could result in a different fair value measurement at the reporting date.
11
The Clorox Company 401(k) Plan
Notes to Financial Statements (continued)
3. Fair Value Measurements (continued)
The following table sets forth by level, within the fair value hierarchy, the Plan’s assets carried at fair value.
| Fair Value as of December 31, 2017 | ||||||
| Level 1 | Total | |||||
| Mutual funds | $ | 699,596,606 | $ | 699,596,606 | ||
| Company's common stock | 115,802,141 | 115,802,141 | ||||
| Self directed brokerage account | 20,420,080 | 20,420,080 | ||||
| Total assets in the fair value hierarchy | $ | 835,818,827 | 835,818,827 | |||
| Common collective trust funds measured at NAV, practical expedient | 735,861,801 | |||||
| Investments at fair value | $ | 1,571,680,628 | ||||
| Fair Value as of December 31, 2016 | ||||||
| Level 1 | Total | |||||
| Mutual funds | $ | 568,306,297 | $ | 568,306,297 | ||
| Company's common stock | 100,866,145 | 100,866,145 | ||||
| Self directed brokerage account | 17,506,904 | 17,506,904 | ||||
| Total assets in the fair value hierarchy | $ | 686,679,346 | 686,679,346 | |||
| Common collective trust funds measured at NAV, practical expedient | 625,038,563 | |||||
| Investments at fair value | $ | 1,311,717,909 | ||||
The common collective trust funds measured at NAV above may impose, in its sole discretion, a prior notice period of up to 12 months for Plan initiated withdrawal of assets. They may also require that within 90 days from withdrawal from the fund, money from the fund cannot be invested directly into a competing fund.
12
The Clorox Company 401(k) Plan
Notes to Financial Statements (continued)
4. Income Tax Status
The Plan has received a determination letter from the Internal Revenue Service (the “IRS”) dated March 8, 2017, stating that the Plan is qualified under Section 401(a) of the Code, and therefore the related trust is exempt from taxation. Subsequent to this determination by the IRS, the Plan was amended. The Plan’s management believes that the Plan is being operated in accordance with the applicable requirements of the Code and therefore believes that the Plan, as amended, is qualified and the related trust is tax-exempt. The Company has indicated that it will take the necessary steps, if any, to maintain the Plan’s operations in compliance with the Code.
U.S. GAAP requires plan management to evaluate uncertain tax positions taken by the Plan. The financial statement effects of a tax position are recognized when the position meets certain recognition thresholds or measurement standards defined by U.S. GAAP. The plan administrator has analyzed the tax positions taken by the Plan, and has concluded that as of December 31, 2017, there are no uncertain positions taken or expected to be taken. The Plan has recognized no interest or penalties related to uncertain tax positions. The Plan may be subjected to routine audits by taxing jurisdictions; however, there are currently no audits in progress for any tax periods.
5. Party-in-Interest Transactions
Transactions in shares of the Company’s common stock qualify as party-in-interest transactions under the provisions of ERISA. During the Plan year ended December 31, 2017, the Plan purchased or received approximately $4,632,000 and sold or distributed approximately $15,824,000 of the Company’s common stock.
Certain Plan assets are invested in funds managed by Vanguard, the Trustee. Consequently, transactions with the Trustee qualify as party-in-interest transactions for which a statutory exemption exists.
6. Subsequent Event
The Plan was amended in 2018, following the Company’s acquisition of Nutranext, LLC and its subsidiaries (“Nutranext”), to add provisions that apply to certain employees of Nutranext. These provisions include prior service counting, loans, rollovers and eligibility for matching and non-elective contributions.
13
Supplemental Information
14
The Clorox Company 401(k) Plan
EIN: 31-0595760 Plan: 001
Schedule H, Line 4a – Schedule of Delinquent Participant Contributions
December 31, 2017
| Totals that constitute nonexempt prohibited transactions | ||||||||
| Participant | Contributions | Total fully | ||||||
| contributions | Contributions | pending | corrected under | |||||
| transferred late | Contributions | corrected | correction | VFCP and PTE | ||||
| to Plan | not corrected | outside VFCP | in VFCP | 2002-51 | ||||
| 4,233 | 4,233 | |||||||
15
The Clorox Company 401(k) Plan
EIN: 31-0595760 Plan: 001
Schedule H, Line 4i – Schedule of Assets (Held at End of Year)
December 31, 2017
| (b) | (c) | (e) | |||||
| Identity of Issue, Borrower, | |||||||
| Description of Investment, Including | |||||||
| Maturity Date, Rate of Interest, | |||||||
| (a) | Lessor, or Similar Party | Collateral, Par, or Maturity Value | Current Value | ||||
| * | Vanguard Institutional Index Fund | Mutual fund | $ | 171,207,342 | |||
| Eaton Vance Atlanta Capital SMID Cap R6 Fund | Mutual fund | 143,922,291 | |||||
| * | Vanguard Institutional Total Bond Index Fund | Mutual fund | 105,193,494 | ||||
| * | Vanguard Institutional Total International Stock Index | Mutual fund | 90,651,431 | ||||
| * | Vanguard Institutional Mid-Cap Index Fund | Mutual fund | 77,070,644 | ||||
| MFS Institutional International Equity Fund | Mutual fund | 53,862,538 | |||||
| * | Vanguard Small Cap Index Fund | Mutual fund | 35,398,308 | ||||
| Metropolitan West Total Return Bond Fund | Mutual fund | 22,290,558 | |||||
| 699,596,606 | |||||||
| T. Rowe Price Growth Stock Trust Class B | Common collective trust fund | 122,498,305 | |||||
| Wells Fargo Stable Return Fund W | Common collective trust fund | 90,147,352 | |||||
| Boston Partners Large Cap Value Equity Trust B | Common collective trust fund | 17,283,672 | |||||
| * | Vanguard Target Retirement Income Trust II | Common collective trust fund | 13,546,572 | ||||
| * | Vanguard Target Retirement 2015 Trust II | Common collective trust fund | 24,876,033 | ||||
| * | Vanguard Target Retirement 2020 Trust II | Common collective trust fund | 41,406,032 | ||||
| * | Vanguard Target Retirement 2025 Trust II | Common collective trust fund | 113,389,025 | ||||
| * | Vanguard Target Retirement 2030 Trust II | Common collective trust fund | 43,172,345 | ||||
| * | Vanguard Target Retirement 2035 Trust II | Common collective trust fund | 114,059,475 | ||||
| * | Vanguard Target Retirement 2040 Trust II | Common collective trust fund | 33,626,162 | ||||
| * | Vanguard Target Retirement 2045 Trust II | Common collective trust fund | 89,300,127 | ||||
| * | Vanguard Target Retirement 2050 Trust II | Common collective trust fund | 17,178,043 | ||||
| * | Vanguard Target Retirement 2055 Trust II | Common collective trust fund | 13,709,532 | ||||
| * | Vanguard Target Retirement 2060 Trust II | Common collective trust fund | 1,667,467 | ||||
| * | Vanguard Target Retirement 2065 Trust II | Common collective trust fund | 1,659 | ||||
| 735,861,801 | |||||||
| * | The Clorox Company Common Stock | Common stock | 115,802,141 | ||||
| Vanguard Brokerage Option | Self-directed brokerage account | 20,420,080 | |||||
| * | Participant loans | Interest rates ranging from 4.25% to 9.50% | 19,275,955 | ||||
| Total investments | $ | 1,590,956,583 | |||||
| * | Indicates a party-in-interest to the Plan. | ||||||
16
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the trustees (or other persons who administer the employee benefit plan) have duly caused this annual report to be signed on its behalf by the undersigned hereunto duly authorized.
| THE CLOROX COMPANY 401 (K) PLAN (FORMERLY THE CLOROX COMPANY EMPLOYEE RETIREMENT INVESTMENT PLAN) | |||
| Date: June 29, 2018 | /s/ Laura Stein | ||
| Laura Stein | |||
| Executive Vice President – General Counsel | |||
| and Corporate Affairs | |||
17
Index to Exhibits
| Exhibit No. | Description | |
| 23.1 | Consent of Moss Adams LLP |
18